Avid Bioservices Inc (CDMO)

[biopharm]

A star was rising fast, with the late Dr Phil Thorpe making the discoveries surrounding the IP assets, first thinking it had to be Targeting the blood vessels and in wonder exactly how the full MOA acted upon the cancers he seen being completely eradicated.

It turns out it was too much for Big Pharma to handle ....the cartel days were beginning to be realized, would be over....IF PS Targeting was allowed to flourish and something had to be done till it could be controlled and managed for combo IO

So we will skip all the sabotages and pay offs...to our latest, plan...to shift the IP assets.

From the prior post:

..the exosomes technology is also being used it looks like with BIA Separations with the help of ex VP Process Science at Avid = Peter Gagnon

His welcome at BIA hid the fact he was with Avid Bioservices and there is much more ...

By BIA Separations | September 11, 2019

...
...
...

"The cornerstone of any new construction project defines it future," said Pete Gagnon, chief scientific officer at BIA Separations. "This is the principle behind our process development program, and we look forward to it becoming the cornerstone of many clinical successes. Over the coming months, we will introduce additional tools and procedures to help scientists meet the unique challenges they face with bringing new therapeutic classes to clinical trials, and eventually to commercial production. Starting with AAVs, the program will expand to include other viral vectors, exosomes, mRNA, and DNA plasmids, among other emerging prospects."
...
...
___


All Peter Gagnon latest patents belong to "AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH" in Singapore

https://patents.justia.com/inventor/peter-gagnon

https://www.a-star.edu.sg/

Why the hell would John Springs Stafford be part of shifting the IP over to Oncologie Inc when the money backers are now being tied to IP assets that have HELPED secure other patents that required the knowledge of PS Targeting IP?

A star was born with the late Dr Phil Thorpe....and a fraud was born with MANY that have remained silent, received payoffs in some fashion....just as Jeanette Bleecker at CSM Clinical Supplies Management with CEO Gerald Finken...

Information overload will be broken down one step at a time ....

So now for one step on this ladder of information is "Andrew F Dorr" who KNOWS PS Targeting leads to the most robust immune response and has seen the list of Biomarkers ....

. .yet, another ...that signs a non disclosure agreement as John Springs Stafford had a job to do ....

______


Andrew F Dorr -

April 21, 2017

F. Andrew Dorr, M.D., the Company’s previous interim chief medical officer, will transition his work to focus on the clinical development of the Company’s oncology programs.

https://seekingalpha.com/filing/3510273

______

Andrew F Dorr, who was not on research published reports of Peregrine re: biomarkers ...but does show up with Joe Shan, Steve King and Nikoletta Kallinteris with patent date filing below...dated

(Page 8 of 12 ...verified that MOS not met yet )

(54) METHODS FOR TREATING CANCER USING PS-TARGETING ANTIBODIES WITH IMMUNO -ONCOLOGY AGENTS

(71) Aplicant:
ONCOLOGIE,INC.,
WestNewton, MA (US)

(72) Inventors:

JosephS.Shan,Tustin,CA(US); NikoletaL.Kalinteris,Tustin,CA(US);
Min Tang,Tustin,CA (US);
F. Andrew Dorr,Tustin,CA (US)

(21) Apl.No.:15/943,304

(2)Filed: Apr.2,2018

https://patentimages.storage.googleapis.com/b4/e9/50/d138e8f8a7a2b2/US20180289771A1.pdf

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152598840

______

Andrew F Dorr consultant for S-BIO and I wonder how the investigations are coming along .....because why in the world would so many want so much from everyone involved with those Biomarkers and protein pathways...

_____

Who knows, maybe S-Bio Pte Ltd wants a piece of the IP asset knowledge


S*BIO Pte Ltd

S*BIO Pte Ltd., a biotech company, focuses on the discovery, research, and clinical development of small molecule drugs.
Singapore, Central Region, Singapore

Categories
Biotechnology, Genetics, Life Science

Headquarters Regions
Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia

Sub-Organization of
Logo of Chiron Corporation
Chiron Corporation

Founded Date
2000

Operating Status
Active

IPO Status
Private

S*Bio Pte Ltd. (Singapore), The principle activity of the company is the discovery and development of novel, proprietary small molecule anti-cancer drugs. This is done through an in-house discovery team located in Singapore and a clinical development team located in Singapore and Calfornia.


https://www.crunchbase.com/organization/s-bio-pte-ltd

_____